Apr 29 |
Hyperfine, Inc. to Announce First Quarter 2024 Financial Results on May 13, 2024
|
Apr 23 |
Hyperfine, Inc. Takes the Stage at ISMRM with Seventeen Abstracts Assessing the Potential of Using Swoop® System Images Across Multiple Care Settings and Clinical Conditions
|
Apr 17 |
Leading Institutions Enroll First Alzheimer’s Patients Receiving Amyloid-Targeting Therapy in CARE PMR Study
|
Mar 21 |
Hyperfine, Inc. (HYPR) Q4 2023 Earnings Call Transcript
|
Mar 21 |
Hyperfine GAAP EPS of -$0.15 beats by $0.03, revenue of $2.69M misses by $1.02M
|
Mar 21 |
Hyperfine, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
|
Mar 12 |
Hyperfine, Inc. Collaborates with King’s College London to Demonstrate the Swoop® System and UNITY Project to The Princess Royal
|
Mar 7 |
Hyperfine, Inc. to Announce Fourth Quarter and Full Year 2023 Financial Results on March 21, 2024
|
Feb 28 |
Hyperfine, Inc. to Present at the Oppenheimer 34th Annual Healthcare Conference
|
Feb 21 |
Hyperfine, Inc. Announces Collaboration with Athletic Heart to Provide Vital Brain Health Imaging for Former Professional Athletes
|